308 related articles for article (PubMed ID: 29393396)
1. PFKFB3 is involved in breast cancer proliferation, migration, invasion and angiogenesis.
Peng F; Li Q; Sun JY; Luo Y; Chen M; Bao Y
Int J Oncol; 2018 Mar; 52(3):945-954. PubMed ID: 29393396
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer.
O'Neal J; Clem A; Reynolds L; Dougherty S; Imbert-Fernandez Y; Telang S; Chesney J; Clem BF
Breast Cancer Res Treat; 2016 Nov; 160(1):29-40. PubMed ID: 27613609
[TBL] [Abstract][Full Text] [Related]
3. Lymphotoxin-α promotes tumor angiogenesis in HNSCC by modulating glycolysis in a PFKFB3-dependent manner.
Yang JG; Wang WM; Xia HF; Yu ZL; Li HM; Ren JG; Chen G; Wang BK; Jia J; Zhang W; Zhao YF
Int J Cancer; 2019 Sep; 145(5):1358-1370. PubMed ID: 30785217
[TBL] [Abstract][Full Text] [Related]
4. PFKFB3 blockade inhibits hepatocellular carcinoma growth by impairing DNA repair through AKT.
Shi WK; Zhu XD; Wang CH; Zhang YY; Cai H; Li XL; Cao MQ; Zhang SZ; Li KS; Sun HC
Cell Death Dis; 2018 Apr; 9(4):428. PubMed ID: 29559632
[TBL] [Abstract][Full Text] [Related]
5. Dual targeting of retinoid X receptor and histone deacetylase with DW22 as a novel antitumor approach.
Wang L; Chen G; Chen K; Ren Y; Li H; Jiang X; Jia L; Fu S; Li Y; Liu X; Wang S; Yang J; Wu C
Oncotarget; 2015; 6(12):9740-55. PubMed ID: 25762635
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
7. 6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27.
Yalcin A; Clem BF; Imbert-Fernandez Y; Ozcan SC; Peker S; O'Neal J; Klarer AC; Clem AL; Telang S; Chesney J
Cell Death Dis; 2014 Jul; 5(7):e1337. PubMed ID: 25032860
[TBL] [Abstract][Full Text] [Related]
8. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancer.
Yu W; Chai H; Li Y; Zhao H; Xie X; Zheng H; Wang C; Wang X; Yang G; Cai X; Falck JR; Yang J
Toxicol Appl Pharmacol; 2012 Oct; 264(1):73-83. PubMed ID: 22841774
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rd regulates the Akt/mTOR/p70S6K signaling cascade and suppresses angiogenesis and breast tumor growth.
Zhang E; Shi H; Yang L; Wu X; Wang Z
Oncol Rep; 2017 Jul; 38(1):359-367. PubMed ID: 28534996
[TBL] [Abstract][Full Text] [Related]
11. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
Xiong J; Yang Q; Li J; Zhou S
Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
[TBL] [Abstract][Full Text] [Related]
12. Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy.
Li X; Liu J; Qian L; Ke H; Yao C; Tian W; Liu Y; Zhang J
Mol Cell Biochem; 2018 Aug; 445(1-2):123-134. PubMed ID: 29327288
[TBL] [Abstract][Full Text] [Related]
13. CCR6 promotes tumor angiogenesis via the AKT/NF-κB/VEGF pathway in colorectal cancer.
Zhu CC; Chen C; Xu ZQ; Zhao JK; Ou BC; Sun J; Zheng MH; Zong YP; Lu AG
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):387-397. PubMed ID: 29097259
[TBL] [Abstract][Full Text] [Related]
14. The anti-angiogenic effect and novel mechanisms of action of Combretastatin A-4.
Su M; Huang J; Liu S; Xiao Y; Qin X; Liu J; Pi C; Luo T; Li J; Chen X; Luo Z
Sci Rep; 2016 Jun; 6():28139. PubMed ID: 27338725
[TBL] [Abstract][Full Text] [Related]
15. Arsenic Trioxide Suppressed Migration and Angiogenesis by Targeting FOXO3a in Gastric Cancer Cells.
Zhang L; Liu L; Zhan S; Chen L; Wang Y; Zhang Y; Du J; Wu Y; Gu L
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477221
[TBL] [Abstract][Full Text] [Related]
16. Blockage of glycolysis by targeting PFKFB3 suppresses the development of infantile hemangioma.
Yang K; Qiu T; Zhou J; Gong X; Zhang X; Lan Y; Zhang Z; Ji Y
J Transl Med; 2023 Feb; 21(1):85. PubMed ID: 36740704
[TBL] [Abstract][Full Text] [Related]
17. Liposomes co-Loaded with 6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3 (PFKFB3) shRNA Plasmid and Docetaxel for the Treatment of non-small Cell Lung Cancer.
Chowdhury N; Vhora I; Patel K; Doddapaneni R; Mondal A; Singh M
Pharm Res; 2017 Nov; 34(11):2371-2384. PubMed ID: 28875330
[TBL] [Abstract][Full Text] [Related]
18. Endothelial PFKFB3 plays a critical role in angiogenesis.
Xu Y; An X; Guo X; Habtetsion TG; Wang Y; Xu X; Kandala S; Li Q; Li H; Zhang C; Caldwell RB; Fulton DJ; Su Y; Hoda MN; Zhou G; Wu C; Huo Y
Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1231-9. PubMed ID: 24700124
[TBL] [Abstract][Full Text] [Related]
19. Sonic hedgehog stimulates glycolysis and proliferation of breast cancer cells: Modulation of PFKFB3 activation.
Ge X; Lyu P; Gu Y; Li L; Li J; Wang Y; Zhang L; Fu C; Cao Z
Biochem Biophys Res Commun; 2015 Aug; 464(3):862-8. PubMed ID: 26171876
[TBL] [Abstract][Full Text] [Related]
20. The transcription factor GATA1 and the histone methyltransferase SET7 interact to promote VEGF-mediated angiogenesis and tumor growth and predict clinical outcome of breast cancer.
Zhang Y; Liu J; Lin J; Zhou L; Song Y; Wei B; Luo X; Chen Z; Chen Y; Xiong J; Xu X; Ding L; Ye Q
Oncotarget; 2016 Mar; 7(9):9859-75. PubMed ID: 26848522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
